Ceftolozane/Tazobactam In-Vitro Activity against Clinical Isolates from Complicated Intra-Abdominal Infection Patients in Three Indonesian Referral Hospitals

Complicated intra-abdominal infections (cIAIs) lead to high morbidity and mortality, especially if poorly managed. However, Indonesia’s microbial pattern and susceptibility data are limited, especially for new antibiotics. Ceftolozane/tazobactam (C/T) is reported to be a new potent antibiotic agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Karuniawati, Anis, Ambarwulan, Merry, Shahab, Selvi Nafisa, Moenadjat, Yefta, Lalisang, Toar J. M., Kurniati, Neneng Dewi, Kuntaman, Budipramana, Vicky Sumarki, Lesmana, Tomy, Puspitasari, Iva, Prabowo, Erik, Sasmitasari, Dwi Putranti Chitra, Putri, Dian Oktavianti, Badawi, Amrilmaen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854667/
https://www.ncbi.nlm.nih.gov/pubmed/36671253
http://dx.doi.org/10.3390/antibiotics12010052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854667/
https://www.ncbi.nlm.nih.gov/pubmed/36671253
http://dx.doi.org/10.3390/antibiotics12010052

Ejemplares similares